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Abstract 
The chemical modification of DNA bases plays a key role in epigenetic gene regulation. While much attention has 
been focused on the classical epigenetic mark, 5-methylcytosine, the field garnered increased interest through 
the recent discovery of additional modifications. In this review, we focus on the epigenetic regulatory roles of DNA 
modifications in animals. We present the symmetric modification of 5-methylcytosine on CpG dinucleotide as a key 
feature, because it permits the inheritance of methylation patterns through DNA replication. However, the distribu-
tion patterns of cytosine methylation are not conserved in animals and independent molecular functions will likely be 
identified. Furthermore, the discovery of enzymes that catalyse the hydroxylation of 5-methylcytosine to 5-hydroxy-
methylcytosine not only identified an active demethylation pathway, but also a candidate for a new epigenetic mark 
associated with activated transcription. Most recently, N6-methyladenine was described as an additional eukaryotic 
DNA modification with epigenetic regulatory potential. Interestingly, this modification is also present in genomes 
that lack canonical cytosine methylation patterns, suggesting independent functions. This newfound diversity of DNA 
modifications and their potential for combinatorial interactions indicates that the epigenetic DNA code is substan-
tially more complex than previously thought.
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Background
To establish and maintain cellular identity during devel-
opment, specific memory mechanisms have evolved that 
regulate gene expression patterns epigenetically. Once 
determined, these lineage-specific expression profiles 
have to be maintained through cell divisions. Active or 
inactive states of gene expression are defined by specific 
epigenetic modification patterns that are either acces-
sible to transcription factors and activators, or result in 
a closed chromatin structure that prevents activated 
transcription [1–3]. Central to this is the concept of 
epigenetic marks, specific DNA or chromatin modifica-
tions that can be inherited through cell divisions. These 
marks maintain the epigenetic information and serve as 
interaction sites for specific binder or reader proteins, 
which include epigenetic modifier enzymes, repressors, 
chromatin remodeling complexes and the transcription 
machinery. The most prominent of these marks is the 
methylation of the carbon-5 of cytosine (5mC), which 
is traditionally considered incompatible with activated 
transcription when present near gene regulatory regions. 
At these regions, 5mC can modulate the binding of tran-
scription factors [4, 5] or induce the binding of specific 
5mC-binding proteins that can lead to the recruitment of 
co-repressor complexes to methylated target promoters 
[6].
While there is an enormous number of published 
studies on epigenetic modifications, most of them are 
correlative in nature. This is exemplified by the increas-
ing use of powerful genome-wide mapping technolo-
gies that have revealed numerous associations between 
changes in epigenetic modification patterns and cell fate 
transitions [7–9]. However, functional insight remains 
relatively limited. Furthermore, the field has broadened 
significantly through the discovery of two additional 
DNA modifications with epigenetic regulatory functions, 
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5-hydroxymethylcytosine (5hmC) and N6-methylad-
enine (6mA), as well as the identification of the corre-
sponding modifying enzymes (Figure 1). Our review aims 
to illustrate the epigenetic regulatory functions of these 
DNA modifications, with a predominant focus on animal 
models. Epigenetic regulation in plants has recently been 
reviewed elsewhere [10–12].
5‑Methylcytosine: the fifth base
5-Methylcytosine has been termed the “fifth base” of the 
human genome. This reflects the relatively high abun-
dance of this modification, as about 4% of the cytosine 
residues in the human genome have been found to be 
methylated. However, cytosine methylation levels can 
differ greatly among animal genomes (see below), and it 
would therefore be misleading to define the significance 
of 5mC by its abundance. Rather, the key feature of cyto-
sine methylation is its enrichment or even specificity for 
“symmetric” CpG dinucleotides [13]. Symmetric methyl-
ation means that methylation marks are present on both 
strands of DNA and that methylation patterns can be 
faithfully propagated through DNA replication by copy-
ing from the parental strand to the unmethylated newly 
synthesized strand. This methylation maintenance is car-
ried out by the Dnmt1 DNA methyltransferase that has a 
strong preference for hemimethylated DNA and provides 
a key paradigm for the stability and heritability of epige-
netic information [14]. Dnmt1 is complemented by the 
Dnmt3 DNA methyltransferases that do not show any 
selectivity for hemimethylated DNA and have therefore 
been termed “de novo methyltransferases” [14]. Together, 
both enzymes catalyze the establishment and mainte-
nance of cytosine DNA methylation patterns during ani-
mal development and cell fate specification.
While the overall specificity of animal methylation 
patterns for CpG dinucleotides has been confirmed in 
numerous studies, several notable exceptions have also 
been described. A prominent example is non-CpG meth-
ylation in mouse embryonic stem cells (ESCs), which was 
verified in the first genome-wide methylation analysis of 
ESCs [15]. While levels of non-CpG methylation are very 
low in most somatic tissues, extensive postnatal accu-
mulation of this modification has been observed in the 
mouse and human brain [16–18]. Targeted depletion of 
Dnmt3a in specific brain regions resulted in significant 
reduction of non-CpG methylation [18, 19]. In contrast 
to ESCs where non-CpG methylation seems to correlate 
with gene expression [15], the modification exhibited an 
inverse correlation with transcription in neurons, which 
could partly be explained through the recruitment of the 
methyl-CpG binding protein 2 (MeCP2) [18, 19]. Context 
dependent non-CpG methylation might therefore have 
an impact on specific readers of DNA methylation, thus 
influencing tissue-specific gene expression.
Beyond mammalian methylomes, the comparative 
analysis of single-base resolution methylation maps has 
shown a substantial degree of variation between animal 
species [15, 20, 21]. The available information can be used 
to define three major categories (Figure 2): the first group 
is defined by mammalian methylomes and is character-
ized by pervasive methylation. In the human genome, 
more than 80% of the CpG dinucleotides are methylated, 
Figure 1 DNA modifications with epigenetic regulatory functions and their interdependencies. Cytosine (C) is methylated to 5-methylcytosine 
(5mC) by DNA methyltransferases (DNMT) and then further oxidised to 5hmC, 5fC and 5caC by Tet dioxygenases. 5-Hydroxyuracil (5hmU) is 
produced by Tet-catalysed oxidation of thymine (T). N6-methyladenine (6mA) is likely catalysed by DNA N6 adenine methyltransferases (DAMT-1 
in C. elegans), even though the biochemical activity of these enzymes remains to be characterized. The Tet-like ALKB enzymes NMAD (N6-methyl 
adenine demethylase 1) and DMAD (DNA 6mA demethylase) have been shown to be involved in 6mA demethylation in C. elegans and in Dros-
ophila, respectively, possibly by using a conserved dioxygenase mechanism.
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creating a landscape of ubiquitous methylation, but with 
local gaps that are often found at active regulatory ele-
ments, such as promoters and enhancers (Figure  2). It 
seems plausible to assume that the default state of these 
methylomes is “methylated” and that active mechanisms 
(see below) are required to keep specific regions free of 
methylation.
The second group is exemplified by the honeybee 
methylome, that can be defined by only 60,000 CpG-
specific methylation marks that are highly enriched in 
exons [22]. In this case, the default state of the genome 
appears to be “unmethylated” and the selective targeting 
of DNA methyltransferases to specific CpGs would be a 
key step for shaping the methylation landscape (Figure 2). 
Such sporadic methylation patterns have been described 
in several animals, particularly in insects. However, the 
functional significance of sparse methylation remains to 
be fully understood, which is largely due to the limited 
potential of the corresponding organisms for genetic 
manipulation. Importantly,  it has been shown that 
queen-like phenotypes can be enhanced in honeybees 
following siRNA-mediated knockdown of the Dnmt3 
orthologue [23]. While the mechanisms underlying 
this phenomenon remain to be elucidated, these results 
strongly suggest a functional role of this enzyme in caste 
specification, possibly through the modulation of caste-
specific methylation patterns.
Finally, several animal genomes have failed to reveal 
canonical cytosine methylation patterns (Figure  2), 
which implies that 5mC is not essential for develop-
ment and cell fate specification of well-known laboratory 
models such as S. cerevisiae, S. pombe, C. elegans and D. 
melanogaster [24]. The absence of conserved cytosine 
methylation patterns in these organisms was instrumen-
tal for the identification and characterization of other 
epigenetic mechanisms, including covalent histone mod-
ifications and small noncoding RNAs [25–27]. Moreover, 
it also played an important role in the recent discovery of 
N6-methyladenine as an epigenetic DNA modification in 
eukaryotes (see below).
The functional analysis of cytosine methylation has 
proven to be surprisingly complex and difficult, even in 
well-characterized mammalian organisms. While knock-
out models demonstrated a role of Dnmt1 and Dnmt3 in 
mouse development [28, 29] and in general epigenetic 
phenomena, such as genomic imprinting [30], X-chro-
mosome inactivation [31] and transposon control [32], 
the specific function of cytosine methylation in epige-
netic gene regulation remains to be fully understood. 
However, recent integrative studies that combine the 
targeted disruption of Dnmt genes with genome-wide 
mapping approaches have provided interesting insight 
into the functional specificities of individual Dnmts. For 
example, Dnmt3a-mediated gene body methylation at 
transcriptionally active genes was shown to be prevalent 
in postnatal neuronal stem cells and is required for post-
natal neurogenesis [33]. In addition, other Dnmts were 
found to interact with actively transcribed gene bodies, 
suggesting that gene body methylation promotes tran-
scription [34]. Most recently, Dnmt3b-mediated gene 
body methylation in mouse ESCs was shown to depend 
on the presence of histone H3 lysine 36 methylation in 
the same regions [35]. This represents a novel and unex-
pected feature of de novo methyltransferases, as it sug-
gests the recruitment of cytosine methyltransferases by 
the co-transcriptional modification of histones.
Figure 2 Three major categories of animal methylomes. Ubiquitous, sporadic and absent DNA methylation (5mC) are illustrated with three 
examples from whole-genome bisulfite sequencing analyses of mouse (top), honey bee (middle) and Drosophila DNA (bottom). Methylation ratios 
for each CpG dinucleotide in a randomly selected 40 kB window are shown. Gene features are indicated below each panel. Transparent blue bars 
indicate the range of bisulfite conversion artifacts (methylation ratios below 0.2).
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In another study, it was shown that human embryonic 
stem cells lacking both DNMT3A and DNMT3B pro-
gressively lose cytosine methylation marks, thus illustrat-
ing an imperfect maintenance activity of DNMT1 and 
a supporting role of DNMT3 enzymes in maintenance 
methylation [36]. Similar results were obtained with 
Dnmt-deficient mouse ESCs, which also revealed differ-
ential specificities of Dnmt1 and Dnmt3a/b for distinct 
subclasses of retrotransposons [37]. Further analyses of 
human ESCs revealed a novel role of DNMT3A in the 
hypermethylation of genes associated with endoderm 
differentiation and a rapid, replication-dependent loss of 
global DNA methylation in DNMT1-deficient cells [36]. 
It will be important to use similar approaches for the 
characterization of additional cell types and model sys-
tems in order to fully understand the epigenetic regula-
tory function of 5mC.
5‑Hydroxymethylcytosine: oxidation creates a new 
modification
With the discovery of the catalytic dioxygenase activity of 
Ten eleven translocation (Tet) proteins, novel epigenetic 
DNA modifications started to emerge [38, 39]. 5-Hydrox-
ymethylcytosine (5hmC, Figure 1) was originally discov-
ered in mammalian DNA in 1972 [40], but its biological 
significance was investigated only almost 40  years later 
[41]. Cytosine hydroxymethylation levels are often 
around 0.1% in mammalian tissues, but can vary greatly 
[42], with highest values in the brain, where up to 1% of 
the cytosines can be hydroxymethylated [41]. The three 
mammalian Tet homologues generate 5hmC from exist-
ing 5mC, which they can further process to 5-formylcy-
tosine (5fC) and 5-carboxylcytosine (5caC, Figure 1) [43, 
44]. About 30,000 molecules of 5mC, 1,300 of 5hmC, 20 
of 5fC, and 3 of 5caC were found per million Cs in mouse 
embryonic stem cells [44, 45], indicating a very low abun-
dance of 5fC and 5caC. As both modifications are tar-
geted by base excision repair mechanisms mediated by 
thymine-DNA-glycosylases, they are mainly interpreted 
as intermediates of an active demethylation pathway via 
Tet-dependent 5mC oxidation [43, 44].
We are only beginning to understand the functional 
significance of 5hmC as an epigenetic mark and the spe-
cific roles of the three Tet enzymes. Tet1 and Tet2 are 
highly expressed in mouse ESCs, but their single deple-
tion does not affect pluripotency or development [46–
49]. Tet3 homozygous mutant mice develop properly, but 
die at birth [50], suggesting that Tet3 is also dispensable 
for embryonic development. ESCs deficient for both Tet1 
and Tet2 show insignificant levels of 5hmC, but retain 
pluripotency. However, the majority of mice lacking 
both proteins showed developmental defects, which was 
found to be associated with ectopic hypermethylation 
[51]. Combined deficiency of all three Tet proteins in 
ESCs depleted 5hmC completely, but did not affect ESC 
viability and pluripotency [52–54]. Nevertheless, triple 
knockout ESCs and embryoid bodies showed impaired 
differentiation potential, promoter hypermethylation and 
correlated deregulation of genes implicated in embry-
onic development and differentiation [52]. In agreement, 
severe defects in somatic cell reprogramming and mesen-
chymal-epithelial transition have been described in dou-
ble and triple Tet knockout mouse embryonic fibroblasts 
[53].
These data point to a major role of Tet-mediated oxi-
dation in DNA demethylation, most likely by keeping 
regulatory genomic regions free of 5mC. Particularly 
important are enhancers, that have been shown to be 
hypermethylated in Tet-deficient mouse ESCs, resulting 
in a reduced activity of associated differentiation genes 
[54, 55]. Tet-dependent oxidation of 5mC as a first step 
of active demethylation is therefore an early event of 
enhancer activation [54–56], but might also more gener-
ally allow functional interactions with regulatory DNA 
elements and counteract aberrant spreading of DNA 
methylation into CpG islands [57].
Nevertheless, 5hmC was also found as a relative stable 
base at a subset of mammalian promoters, at gene bod-
ies of actively transcribed genes and at poised and active 
enhancers [58, 59]. 5fC was also mapped to a subset of 
these 5hmC-marked regions [60–62], suggesting a role as 
an independent epigenetic mark. Indeed, several “reader” 
proteins for oxidised 5mC-derivatives have been identi-
fied, which might mediate epigenetic regulation [63, 64]. 
Among these were, in addition to DNA damage- and 
repair-related proteins, chromatin modifiers and tran-
scriptional regulators like e.g. MBD3, MeCP2, UHRF2 
and FOX transcription factors [64–66]. While the 
functional relevance and specificity of the interactions 
remains to be fully understood (e.g. many 5hmC interact-
ing proteins also have significant affinities for 5mC) these 
readers might recruit chromatin regulatory complexes to 
their targets and support activated transcription.
A role of 5hmC as active mark is supported by mass 
spectrometric analyses of isotope labelled DNA form 
mammalian cell culture and mice showing that 5hmC is 
mostly a stable modification and not a transient inter-
mediate [67]. The high abundance in post-mitotic brain 
tissues [41, 42] also suggests a direct epigenetic function 
of 5hmC. Indeed, 5hmC levels increase during neuronal 
differentiation and a very stable intragenic enrichment of 
5hmC was observed at many active neuron-specific genes 
[66, 68–70]. These findings suggest that 5hmC functions 
as epigenetic mark in mammalian neuronal development. 
This is further supported by the observations that the 
activated human HOXA cluster becomes stably enriched 
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in 5hmC upon retinoic acid stimulated neuronal differen-
tiation [71] and that increased 5hmC levels at neuronal 
marker genes in Sirtuin-6-deficient mice induce skewed 
differentiation versus neuroectoderm [72].
While there is evidence for a direct epigenetic func-
tion for 5hmC at least in some tissues, a similar role for 
its oxidation derivatives appears less likely. The levels of 
5fC and 5caC have been found to increase at 5fC sites in 
thymine-DNA-glycosylase-deficient mouse ESCs, sug-
gesting that 5caC sites primarily represent sites of active 
demethylation [60–62]. It remains possible that, due to 
the chemical differences between the oxidised 5mC-
derivatives, each modification might attract specific 
readers. However, considering the relatively strong DNA-
damage response triggered by 5fC and 5caC (in contrast 
to 5hmC) and their very low abundances, it seems more 
likely that these modifications transiently accumulate 
at the regions of the hydroxymethylome that under-
goes demethylation. In contrast, a subset of 5hmC sites 
appears to be stable and might act as an independent epi-
genetic mark. Very recently, it has been shown that Tet 
proteins can also oxidize thymine to 5-hydroxymethylu-
racil (5hmU, Figure 1) [73]. Tet-dependent 5hmU is pre-
sent at levels similar to 5caC in mESCs, increases during 
early ESC differentiation and recruits specific interacting 
proteins [73], suggesting an epigenetic function for Tet-
dependent 5hmU. Nevertheless, 5hmU paired with ade-
nine is a target for the Smug1 DNA glycosylase [74] and 
might therefore trigger base excision repair mechanisms. 
Indeed knock down of Smug1 in mESCs led to increased 
5hmU levels [73], indicating that 5hmU might also serve 
to promote active demethylation by recruiting repair fac-
tors to Tet targets.
N6‑methyladenine: revival of an old acquaintance
In bacterial genomes 5mC is outshined by a second 
base modification, N6-methyladenine (6mA, Figure  1). 
Adenine methylation has been shown to be essential for 
the viability of several bacteria, as methylation of GATC 
sequences by the Dam methylase creates specific marks 
that are important for DNA replication, chromosome 
segregation, mismatch repair and the regulation of gene 
expression [75, 76]. However, several older studies also 
suggested the presence of 6mA in eukaryotic genomes, 
even though detection was often indirect and modifi-
cation levels appeared close to the detection limit [76]. 
Several unicellular eukaryotes, including the green alga 
Chlamydomonas reinhardtii, had consistently shown 
comparably high levels of DNA adenine methylation [76], 
which established this organism as an attractive model to 
investigate 6mA further.
Over the past few years, several powerful technolo-
gies were developed to analyze 6mA in RNA, where this 
modification plays an important regulatory role. When 
these methods were adapted to characterize the distribu-
tion of 6mA in the Chlamydomonas genome, some key 
characteristics of this modification could be defined [77]. 
For example, the results showed that the algal adenine 
methylome consists of about 85,000 fully methylated 
6mA sites, corresponding to a global adenine methyla-
tion level of approximately 0.4%. Methylation was often 
found in symmetric ApT target sequences, but there was 
no evidence for symmetric 6mA methylation. The modi-
fication was enriched at promoter regions, and particu-
larly in linker regions between adjacent nucleosomes. 
The authors propose a model in which the DNA 6mA 
modification either restricts or marks the positions of 
nucleosomes near transcriptional start sites in Chla-
mydomonas. As such, the presence of 6mA may posi-
tion nucleosomes to facilitate initiation of transcription. 
While these findings are highly interesting, they are dif-
ficult to generalize because of a highly specific periodic 
pattern of nucleosome occupancy around transcriptional 
start sites in Chlamydomonas. Furthermore, the Chla-
mydomonas genome has an unusual pattern of 5mC: it is 
characterised by low levels of CpG methylation but also 
contains CHG and CHH methylation in gene bodies, 
which corresponds to known plant methylation patterns 
[20].
A parallel study also revealed novel details of adenine 
DNA methylation in Caenorhabditis elegans [78]. Similar 
to Chlamydomonas, adenine methylation was found to 
be variable, and maximum levels were rather low (0.3%). 
Mapping of 6mA residues by SMRT sequencing revealed 
that methylation was targeted to GAGG and AGAA con-
sensus sequences, indicating strand-specific adenine 
methylation. Interestingly, 6mA accumulated in worms 
deficient for spr-5 (coding for a H3K4me2 demethylase), 
an important paradigm of trans-generational epigenetic 
inheritance [78]. Further work led to the identification 
of a C. elegans DNA adenine demethylase (Nmad-1), 
belonging to the ALKB family of dioxygenases that also 
contains the Tet proteins. In addition, the authors identi-
fied a candidate DNA adenine methyltransferase (Damt-
1) related to bacterial 6mA DNA methyltransferases. This 
enzyme belongs to a highly conserved family of proteins 
that is characterized by a C-terminal circularly per-
muted methyltransferase domain fused to a distinctive 
N-terminal domain [79]. While the biochemical activ-
ity of the enzyme remains to be characterized, deletion 
of Damt-1 suppressed the trans-generational phenotypes 
of spr-5 mutant worms, suggesting that 6mA might be a 
transgenerationally inheritable epigenetic mark.
Additional insight into the function of adenine meth-
ylation came from a recent analysis in Drosophila. Flies 
represent a particularly interesting model for DNA 
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modifications, because of the longstanding controversial 
discussions surrounding the cytosine methylation status 
of the Drosophila genome. In addition, the fly genome 
encodes an unusual DNA methylation machinery, with 
no canonical Dnmt1/3 homologue, but with a clear Tet 
homologue. The former is consistent with the reported 
absence of Dnmt-dependent cytosine methylation pat-
terns in Drosophila [24, 80], but the latter seemed to indi-
cate that methylation may have been overlooked so far. 
By using highly sensitive mass spectrometry approaches, 
Zhang et al. have now demonstrated the presence of low 
(0.07%) but significant levels of adenine methylation dur-
ing the earliest stages of Drosophila embryogenesis [81]. 
Most interestingly, the authors showed 6mA demethyla-
tion by the Drosophila Tet homologue DMAD in vitro and 
a specific increase of 6mA levels in the genomic DNA of 
DMAD mutants suggesting that DMAD is a 6mA-specific 
enzyme [81]. Furthermore, both deletion and overexpres-
sion of DMAD resulted in lethality, thus demonstrating an 
important developmental function of 6mA in Drosophila. 
One such function could be the regulation of transpo-
sons, as 6mA appeared enriched in transposon regions 
and transposons marked with 6mA were derepressed in 
DMAD mutants. Taken together, if 6mA will also be found 
in significant quantities in the genome of other eukaryotes, 
it might turn out to be an important carrier of epigenetic 
information, involved in the regulation of gene expression 
and possibly playing a complementary role to 5mC at cer-
tain loci or during specific stages of development.
Conclusions
Epigenetic DNA modifications generally affect the acces-
sibility of genomic regions for regulatory proteins or 
protein complexes, for example by preventing interac-
tions or by recruiting specific readers. Consequently, this 
can influence the chromatin structure and/or directly 
regulate enhancer and promoter activity or transcrip-
tional processivity. Cytosine methylation is so far the 
only known symmetric modification with an established 
maintenance mechanism, which represents a unique fea-
ture that currently distinguishes 5mC from all other epi-
genetic modifications. 5mC has mostly been related to 
gene repression, in particular at enhancer and promoter 
regions of genes (Figure 3), but might also play an impor-
tant role in positively influencing transcription, either by 
recruiting methylation-specific transcription factors [82, 
83] or by a yet to be understood mechanism when pre-
sent in the body of active genes [35].
Dynamic epigenetic processes also require the active 
removal of a mark. With the discovery of the enzymatic 
functions of the Tet proteins, the main enzymes for the 
removal of DNA methylation were identified. 5hmC and 
its Tet-dependent oxidation products are demethyla-
tion intermediates, but might also have significant roles 
as independent epigenetic marks  (Figure  3). Specific 
readers for 5hmC, 5fC and 5caC have been identified 
that function in transcription regulation and chromatin 
remodeling, mostly promoting the active state. In addi-
tion, 5fC, 5caC and 5hmU might primarily function in 
5mC 5-methylcytosine. Repressive mark at enhancers and promoters, enriched in active gene bodies, recruits specific binders. 
5hmC 5-hydroxymethylcytosine. Oxidised 5mC, demethylation intermediate. Active mark at enhancers and gene bodies, recruits specific binders. 
5fC 5-formylcytosine. Oxidised 5hmC, demethylation intermediate, recruitsDNA repair machinery. 
5caC 5-carboxylcytosine. Oxidised 5fC, demethylation intermediate, recruitsDNA repair machinery. 
5hmU 5-hydroxymethyluracil. Oxidised form of thymine, recruits DNA repairmachinery. 
6mA
N6-methyladenine: active mark, enriched at TSS, influences 
nucleosome positioning, demethylation by Tet homologues, correlation 
with H3K4-methylation. 
Figure 3 Modified DNA bases and their functions.
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the recruitment of DNA repair-associated complexes 
and thus enhance demethylation (Figure 3). Finally, these 
marks might also directly contribute to gene regulation 
by triggering “scheduled” DNA repair, which has been 
suggested to be coupled with activated transcription 
[84].
The discovery of 6mA in eukaryotes recently identi-
fied an additional methylation mark  (Figure  3). With C. 
elegans and D. melanogaster, two species with negligible 
5mC/5hmC levels were shown to contain low, but sig-
nificant genomic 6mA levels. In both species, this novel 
modification can be cautiously interpreted as an active 
epigenetic mark, as data from C. elegans suggests a func-
tional interplay with an established active histone mark 
(H3K4me2) [78], whereas in Drosophila mutations in 
the 6mA-demethylase DMAD (a Tet-homologue) caused 
increased transposon expression [81]. In both organisms 
mutations in the 6mA-specific enzymes resulted in sig-
nificant phenotypes (developmental defects, infertility), 
suggesting important roles in development. Also in Chla-
mydomonas, 6mA marks actively transcribed genes near 
the transcriptional start site (TSS).
Future research needs to address the conservation 
of 6mA and the enzymes that can set and remove this 
modification. Interestingly, the candidate C. elegans 
6mA methyltransferase Damt-1 belongs to a widely con-
served family of enzymes [78] that also includes a human 
homologue (METTL4). Nevertheless, reports on 6mA in 
higher eukaryotes have been sparse and the results were 
often inconclusive [76]. Highly sensitive mass spectrom-
etry detected less than one molecule of 6mA per million 
nucleotides in DNA from selected mouse tissues [85], 
suggesting that 6mA is not a constitutive modification, 
or is rapidly turned over by demethylation processes. It 
might be possible to enrich 6mA by depleting the 6mA-
demethylase, as shown for Drosophila [81]. Furthermore, 
additional enzymes potentially involved in adenine meth-
ylation and demethylation in mammals can be identified 
using genome editing tools. Finally, the observation that 
6mA demethylation in Drosophila can be mediated by 
a Tet-like enzyme [81], raises the fascinating possibility 
that cytosine and adenine (de)methylation are coordi-
nated. It will be most interesting to investigate the poten-
tial interplay between specific DNA modifications and to 
explore the full complexity of this epigenetic code.
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